Croda International and The Access to Advanced Health Institute (AAHI) have announced the signing of a partnership agreement around innovation and development of adjuvant formulations, under which Croda and AAHI will leverage their combined expertise to make novel vaccine adjuvant formulations globally accessible, thereby advancing next generation, robust and durable vaccines.
Croda’s Health Care division has become Croda Pharma, bringing its core specialty excipient portfolio together with the recent acquisition, Avanti Polar Lipids and its Adjuvant Systems arm, all under one business.
Market Place
Share
Share
